Coherus BioSciences, Inc. (CHRS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Coherus Oncology (CHRS) Q1 2026: Lactorsi New Patient Starts Jump 21% as Pipeline Readouts Approach
June 17, 2026
-
Coherus Oncology (CHRS) Q2 2025: Lactorzy Revenue Jumps 36% as Pipeline Readouts Near
June 16, 2026
-
Coherence Oncology (CHRS) Q3 2025: Lactorsi Demand Up 92% YoY, Pipeline Data Readouts Set for 2026
June 16, 2026
-
Coherus (CHRS) Q4 2025: Lactorsi Revenue Doubles, Funding 70% Market Share Push
June 15, 2026